Sublingual immunotherapy for allergic rhinitis and asthma

Record ID 32010000867
Authors' objectives:

Sublingual immunotherapy involves the administration of a diluted dose of an allergen under the tongue, which allows the material to contact the oral mucosa. Sublingual immunotherapy has been investigated in patients with allergic rhinitis and/or asthma associated with sensitivity to seasonal allergens, and to allergens such as dust mites, mold, pet dander, or nuts. In contrast to standard immunotherapy, which requires subcutaneous injections, sublingual therapy may offer a lower risk of serious side effects, and may be more comfortable and acceptable to many patients.

Project Status: Completed
URL for project:
Year Published: 2009
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Administration, Sublingual
  • Allergens
  • Asthma
  • Rhinitis
Organisation Name: HAYES, Inc.
Contact Address: 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
Contact Email:
Copyright: 2009 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.